首页> 外文期刊>Antiviral Research >Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
【24h】

Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.

机译:萘啶和2-氨基苯并咪唑类对人免疫缺陷病毒I型整合酶的抑制作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Retroviral integrases catalyze two of the steps of insertion of proviral DNA into the host genomic DNA. Inhibitors that target the second step, strand transfer into the host DNA, have been demonstrated to have antiviral activity in cell culture. We describe two classes of HIV-1 integrase inhibitors that block strand transfer, one based on a naphthamidine core and one on a benzimidazole core. While the naphthamidine compounds showed some propensity to interact with the DNA substrate, both classes were shown to bind directly to integrase. The naphthamidine compounds showed activity in cell culture, and a direct effect on integrase was indicated by an increase in 2-LTR products in the presence of a naphthamidine compound. These two classes of compounds represent potential starting points for the development of new classes of integrase inhibitors.
机译:逆转录病毒整合催化将前病毒DNA插入宿主基因组DNA的两个步骤。已经证明靶向第二步的抑制剂是将链转移到宿主DNA中,在细胞培养中具有抗病毒活性。我们描述了两类阻止链转移的HIV-1整合酶抑制剂,一类基于萘啶核心,一类基于苯并咪唑核心。萘丁烷化合物显示出与DNA底物相互作用的倾向,但两类化合物均直接与整合酶结合。萘啶化合物在细胞培养中显示出活性,并且在萘啶化合物存在下2-LTR产物的增加表明了对整合酶的直接作用。这两类化合物代表了开发新型整合酶抑制剂的潜在起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号